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Abstract
Salmonid alphavirus (SAV) causes disease in farmed salmonid fish and is divided into different
genetic subtypes (SAV1-6). Here we report the cloning and characterization of the 5'- and 3'-
untranslated regions (UTR) of a SAV3 isolated from Atlantic salmon in Norway. The sequences of
the UTRs are very similar to those of SAV1 and SAV2, but single nucleotide polymorphisms are
present, also in the 3' - conserved sequence element (3'-CSE). Prediction of the RNA secondary
structure suggested putative stem-loop structures in both the 5'- and 3'-ends, similar to those of
alphaviruses from the terrestrial environment, indicating that the general genome replication
initiation strategy for alphaviruses is also utilized by SAV. A DNA replicon vector, pmSAV3, based
upon a pVAX1 backbone and the SAV3 genome was constructed, and the SAV3 non-structural
proteins were used to express a reporter gene controlled by the SAV3 subgenomic promoter.
Transfection of pmSAV3 into CHSE and BF2 cell lines resulted in expression of the reporter
protein, confirming that the cloned SAV3 replication apparatus and UTRs are functional in fish cells.
Findings
Salmonid alphaviruses (SAVs) cause disease in farmed sal-
monids both in freshwater and the marine environment
in Europe [1]. The virus, also known as Salmon pancreas
disease virus, was molecularly characterized during the late
1990-ies, and assigned to the genus Alphavirus in the fam-
ily Togaviridae [2,3]. Alphaviruses have single-stranded
RNA genomes of 11-12 kb length with a 5'-terminal cap
and a 3'-terminal polyadenylated tail. The coding
sequences are organized into two large non-overlapping
open reading frames (ORFs) that are flanked by three
untranslated regions (UTRs). The first ORF is approxi-
mately 8 kb and encodes the non-structural proteins
(nsPs) 1-4, while the second ORF is approximately 4 kb
and encodes the structural proteins capsid, E3, E2, 6K, TF
and E1. The second ORF is transcribed from an anti-sense
genome under the control of a subgenomic promoter in
the untranslated region that separates the two ORFs [4,5].
The genome is replicated by the nsPs, which together with
host proteins make up the replicase complex (RC). The
nsPs are translated as a polyprotein, P1234, that is cleaved
by a papain-like serine protease of the nsP2 component.
The different cleavage products of the RC have several
roles during replication that include (i) recognition of
viral genomic RNA and transcription of an anti-sense
genome, (ii) recognition of the anti-sense genome and
transcription of a new genome strand and (iii) recogni-
tion of the subgenomic promoter on the anti-sense
genome and transcription of a subgenomic mRNA that
contains the second ORF. The untranslated regions
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for transcription of genomic and anti-genomic RNA. The
RNA secondary structure found in conserved sequence
elements (CSEs), rather than the primary sequence,
appears to be the prominent factor in the function of these
promoters [6].
Alphaviruses have been widely used in reverse genetics
and protein expression systems. A common strategy used
in alphaviral reverse genetics has been cloning of the viral
genome under the control of an RNA polymerase pro-
moter following transcription into a capped and polyade-
nylated self-replicating RNA [7]. In alphavirus-based
replicons the subgenomic, second ORF is replaced with
that of the gene of interest (GOI). Expression of the GOI
is then executed by the alphavirus replication apparatus.
Such replicons are frequently used for basic studies of
alphavirus replication and for in vivo expression of GOIs,
and can be used as vector systems in vaccination. Alphavi-
ral based expression systems are useful for the latter appli-
cation since they typically provide high expression of the
transgene as well as activation of innate antiviral response
in the transfected/transducted cell [8].
SAV is not genetically homogenous in Europe. Sequence
comparisons of SAV isolates suggest that at least six dis-
tinct virus reservoirs exist and this has resulted in evolu-
tion into the subtypes SAV1-6 [9-11]. The coding
sequence of nsP3 is particularly variable between the sub-
types and contains several insertions/deletions with
unknown effect in the C-terminal region. The SAV2 sub-
type appears to be widespread in freshwater farmed rain-
bow trout in continental Europe, whereas subtypes 1, 4, 5
and 6 have been found in Atlantic salmon from overlap-
ping areas off the coast of Ireland, Northern Ireland and
Scotland. In Norway a genetically homogeneous subtype,
SAV3, is found to infect both Atlantic salmon and rain-
bow trout on the southwest coast, but has only occasion-
ally been found in northern Norway [10,12].
A replicon allowing viral subgenomic promoter-driven
expression of a GOI, as well as a reverse genetics system,
has been developed for an attenuated strain of SAV2 [13].
In that system the SAV2 genome was transcribed by either
T7 RNA polymerase or cellular RNA polymerase II, and
the system has been useful for functional studies of SAV2
[13]. SAV3 and SAV2 represent two subtypes of the Salmo-
nid alphavirus species showing approximately 7.1%
nucleotide sequence differences in their genomic
sequences [10]. SAV3 causes disease in farmed salmonids
in the marine grow-out phase, while SAV2 typically causes
disease in rainbow trout fingerlings. The optimum tem-
perature for replication may also differ, as it appears to be
lower for SAV2 than for SAV3 [1]. In order to learn more
about these differences, we sought to obtain tools to study
the replication apparatus of SAV3. The genomic ends of
SAV3 had not been characterized. Therefore, we cloned
and sequenced these from chinook salmon embryo
(CHSE) cell cultures infected with SAVH20/03 [10] pas-
sage 28, using 5'- and 3'- rapid amplification of cDNA
ends (RACE) kits (Invitrogen) as recommended by the
manufacturer. Nucleotide sequence alignment of SAV3
UTRs with those of SAV1 and SAV2 (sequences of the
UTRs of SAV4-6 subtypes were not available) demon-
strated 100% identity of the 5'-UTR of SAV3 (SAVH20/03)
and SAV2 strain rSDV, while four nucleotide polymor-
phisms were present in the 3'-UTR. Interestingly, one of
these polymorphisms was found in the 3'-CSE (Fig. 1a).
The 3'-CSE is conserved among alphaviruses, and func-
tions as promoter for the initiation of minus-strand tran-
scription [6].
The 5'- and 3'-UTRs of SAV are the shortest known among
alphaviruses [14]. This has caused speculation as to
whether SAV transcription initiation could be independ-
ent of a stem-loop structure in the genomic 5'- end [13].
Since secondary structure rather than nucleotide sequence
in the 5'-UTR is decisive for initiation of genomic replica-
tion in other alphaviruses [6], the lack of a stem-loop in
the SAV 5'-UTR would imply a different strategy for
polymerase/promoter recognition. The distinct phyloge-
netic position of SAV, and vast evolutionary distance from
terrestrial alphaviruses could make this plausible [2,15].
However, in silico analysis using Mfold RNA secondary
structure predictor [16] with folding temperature set to
14°C (the replication temperature for SAV3), suggested
that SAV 5'-UTR might form two short stem-loops in the
5'-end, and that a portion of the coding sequence of nsP1
is likely to be part of the second structure (Fig. 1b). In the
3'-UTR, four stem loops were predicted (Fig. 1c). Due to
the observed polymorphisms in the 3'-CSE, it is predicted
that SAV3 has a slightly longer stem loop than SAV2 (Fig.
1d).
Knowledge of the ultimate ends and thus full-length
sequence of SAV3 (isolate SAVH20/03), allowed construc-
tion of a SAV3 based replicon. Using a similar strategy as
previously used for SAV2 [13], we constructed the plasmid
pmSAV3 (Fig. 2a). The plasmid has the following charac-
teristics: (i) a pVAX1 (Invitrogen) backbone optimized for
DNA-vaccination, with a transcription unit controlled by
the cytomegalovirus (CMV) immediate early promoter
and a bovine growth hormone (BGH) polyadenylation
signal, (ii) the SAV3 genome in which the structural ORF
has been replaced with that of the enhanced green fluores-
cence protein (EGFP), flanked by AgeI and AscI restriction
enzyme sites, (iii) a polyadenylated tail fused directly to
the 3'-UTR of SAV3, and (iv) a hammerhead ribozyme
fused directly to the SAV3 5'-UTR. The latter was included
since a correct genomic 5'-end has been reported to bePage 2 of 6
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Ribozyme generation was done by annealing oligos
5HHribo2/3HHribo2 followed by polymerisation using
Klenow fragment (TaKaRa), as earlier described [13].
Primers and restriction enzyme sites that were used for
cloning purposes are listed in Table 1. The authenticity of
the plasmid construction was verified by EcoRI, AgeI and
AscI (New England Biolabs) digestion (Fig. 2b) and by
sequencing as previously described [12]. This information
indicated that eight substitutions were present in the RC
coding region compared to the nucleotide sequence of
passage 20 of the parental strain SAVH20/03 (Table 2).
One of the substitutions, the R to C in the nsP3 region,
was reported to be present in passage 3 of SAVH20/03
[10], suggesting that it could be part of a viral quasispe-
cies.
Transfection of pmSAV3 into CHSE or BF2 cells using
Amaxa nucleofector kit T (Lonza) or Metafectene Pro
according to producer recommendations resulted in
expression of the EGFP reporter that was visualized by flu-
orescence microscopy (Fig. 2c). In these experiments
transfected cells were kept for 24 h at 20°C, then moved
to 14°C, at which SAV3 replication is efficient [12]. The
incubation step at 20°C enables the efficient transcription
from the CMV promoter, which is more active at 20°C
than at 14°C in CHSE cells (personal observation). In this
SAV3 replicon system, expression of the EGFP reporter
showed slower kinetics compared to the positive control
used, i.e. EGFP under the direct control of the CMV pro-
moter as in the plasmid pEGFP-N1 (Clontech), where
EGFP typically can be observed as early as 6-12 h post
transfection (p.t) (not shown). The earliest SAV3 replicon
expression of EGFP was observed 2 days p.t. in CHSE cells
and 3 days p.t. in BF2 cells. The number of positive cells
peaked between days 6 and 8 p. t. in CHSE cells and
around day 14 p.t. in BF2 cells.
In order to obtain efficient replication the polyadenylated
tail had to be fused directly to the 3'-UTR of the SAV
genome. Versions of pmSAV3 replicon constructs in
which polyadenylation was initiated by the BGH signal in
Cloning and characterization of SAV3 5'- and 3'-endsFigure 1
Cloning and characterization of SAV3 5'- and 3'-ends. The 5'- and 3'-ends of SAV3 were cloned and sequenced from 
the isolate SAVH20/03 and aligned to the 5'- and 3'-UTRs of other SAVs. A) Alignment of the region in the 3'-UTR containing 
a sequence homologous to the alphavirus 19 nt CSE (underlined). B) In silico RNA secondary structure analysis using Mfold of 
SAV3 5'-UTR and partial coding sequence. Red letters indicate coding sequence. C) Predicted RNA secondary structures of 
the 3'-UTRs of SAV2 and SAV3. Position of the polyadenylated tail is indicated.Page 3 of 6
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Construction and evaluation of a SAV3 based repliconFigure 2
Construction and evaluation of a SAV3 based replicon. A) A SAV3 replicon is launched from the CMV promoter (red 
arrow) in the pVAX1 backbone, and transcription stops at the BGH polyA signal (red box). A synthetic DNA encoding a ham-
merhead ribozyme was fused to the SAV3 5'-UTR and a polyadenylated tail was fused to the 3'-UTR. The ORF encoding the 
SAV3 structural proteins was replaced by an ORF encoding EGFP inserted between introduced AgeI and AscI sites. Position of 
the EcoRI site used for restriction enzyme analysis is indicated. B) Restriction enzyme analysis by digestion of pmSAV3 with 
EcoRI, AgeI and AscI. Lane 1: Smartladder (Eurogentec). Lane 2: pmSAV3 after triple digest with EcoRI, AgeI and AscI. Bands 
corresponding to the pVAX1 backbone, nsP coding sequence and EGFP coding sequence are indicated. C) Expression of EGFP 
in BF2 cells after transfection with pmSAV3. Both CHSE and BF2 cells facilitated successful expression of the EGFP reporter. 
EGFP expression became visible from day 2 p.t. in CHSE cells and 3 d.p.t. in BF2 cells.
Table 1: Primers used for construction of pmSAV3. 
Primer Sequence 5'-3' REN site
KP1 CCGAATTCGTTAAATCCAAAAGCATACATATATCAATGATGC EcoRI
KP2 CCCGGGGCGGCCCCAAGGTCGAGAACTGAGTTG
KP3 CCCGGGAGGAGTGACCGACTACTGCGTGAAGAAG
KP4 GGTCTAGAGTATGATGCAGAAAATATTAAGG XbaI
nsP2SacIF GAGCTCATGACTGCGGCTGCC SacI
nsP3HpaIR GTTAACCAAGACTTCCTCTTCGGC HpaI
AscI3UTRF GGCGCGCCATTCCGGTATATAAA AscI
AscIGFPR GGCGCGCCTTACTTGTACAGCTCGTCCATGC AscI
XbaIAgeIKGFPF TCTAGACCAACCACCGGTGCCACCATGGTGAGCAAG XbaI, AgeI
5HHribo2 GGGGAGCTCGCTAGCTGGATTTATCCTGATGAGTCCGTGAGGACG
AAACTATAGGAAAGGAATTCCTATAGTCGATAAATCCAAAAGC
SacI, NheI
3HHribo2 CCCGCCGGCGGAGGGGTTAGCTGTGAGATTTTGCATCATTGATATATG
TATGCTTTTGGATTTATCGACTATAGGAATTCCTT
NaeI
NotIXbaIPolyAR CCGCGGCCGCTCTAGAT25ATTGAAAATTTTAAAAACC NotI, XbaI
NotIXbaIPolyA3R CCGCGGCCGCTCTAGAT23ATATTGAAAATTTTAAAACC NotI, XbaI
Restriction enzyme sites that were used during cloning are indicated in the sequence by bold letters.
Virology Journal 2009, 6:173 http://www.virologyj.com/content/6/1/173the vector backbone were not functional (not shown).
This is similar to previous reports for DNA-launched SINV
replicons [17], and suggests that SAV expression is sensi-
tive for erroneous sequences between the 3'-UTR and the
polyadenylated tail. Presumably, this has a negative effect
on minus-strand synthesis as observed for SINV [18]. A
different construct, pmSAV3M10, where the SAV3 3'-CSE
was exchanged with SAV2 3'-CSE was also tested for its
ability to express the reporter. This plasmid was generated
by amplifying the 3'-UTR with primers AscI3UTRF and
NotIXbaIPolyAR, where the latter primer sequence con-
tained the SAV2 3'-CSE (Table 2). The 3'-UTR of pmSAV3
was then exchanged with the amplification product
through AscI/XbaI cleavage and ligation. In transfection
studies this construct showed expression kinetics similar
to those observed for pmSAV3, confirming that the SAV3
replicase complex is able to recognise the SAV2 3'-CSE
during replication. Moreover, this suggests that the poly-
morphisms observed in the 3'-CSE have little or no impact
for SAV replication, and as predicted by in silico analysis,
are of minor importance for the RNA secondary structure.
The pmSAV3 based plasmids can become valuable tools
for functional studies of the SAV3 that currently is
regarded as enzootic on the Norwegian west coast, but
they may also be used for development of vectored vac-
cines for use in cold-water fish. It will be of interest to
compare the performance of SAV3- and SAV2-based repli-
cons [13] in such studies.
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